INTRODUCTION
Awareness about childhood stroke is increasing. Stroke is among the top 10 causes of death and a significant cause of long-term morbidity in childhood. 1 Stroke is traditionally classified into ischemic and hemorrhagic subtypes. This review focuses on pediatric arterial ischemic stroke (AIS) only.
AIS occurs with a frequency of 2 to 3/100,000 children per year. 2 Many cases occur during the perinatal or neonatal period, during which the incidence is approximately 1 in 4000 live births. 3 Boys are affected more frequently. 4 Pediatric AIS differs from adult AIS in several ways. First, AIS is rarer and has a subtler clinical presentation and a wider differential diagnosis in children, which results in delayed and sometimes missed diagnosis. 5 Second, the coagulation, vascular, and adaptive components of the neurologic systems differ between children and adults. Third, risk factors for pediatric AIS are frequently multiple, age-dependent across childhood, and distinct from those in adults, necessitating a complex set of etiologic investigations. Fourth, there is still a paucity of robust data on the rates of outcomes in children, including stroke volume, recurrent stroke, and chronic disability. Consequently, evidence supporting specific treatments is lacking, leading to variability in management. Consensus-based pediatric stroke treatment guidelines differ from each other in some aspectsVfor example, initial aspirin versus anticoagulation for noncardiac stroke. 6, 7 Finally, the burden of pediatric AIS is longer lasting because a child who survives AIS is expected to live much longer than an adult stroke survivor.
RECOGNITION OF ARTERIAL ISCHEMIC STROKE
Recognition of AIS in neonates and infants is challenging because acute focal neurologic deficits, typically evident in older children and adults, are uncommon. Neonates usually present with seizures and other nonspecific symptoms. 8 AIS should be suspected in any newborn with seizures, particularly when seizures begin more than 12 hours after birth. 9 Neonates may also present with encephalopathy (irritability, lethargy, and poor feeding) or recurrent apnea. Focal deficits occur in less than 25% of all newborns with AIS. Sometimes acute neonatal AIS is not diagnosed until later infancy or childhood when hemiparesis becomes gradually evident with maturation. In such children, imaging shows remote AIS, which is presumed to have occurred in the prenatal or perinatal period and is called ''presumed perinatal ischemic stroke.'' The typical history includes motor delay, early hand dominance (before the first birthday), and focal seizures evolving into a classical hemiplegic cerebral palsy.
With increasing age, acute AIS manifests with a clinical presentation similar to that in adults, namely abrupt onset of focal neurologic deficits. However, pediatric health care providers are still not always attuned to the possibility of stroke in childhood, and delayed diagnosis is a consequence. The most common manifestation is hemiparesis; however, depending on the vascular territory involved, aphasia, ataxia, dysarthria, visual deficits, and cranial nerve palsies can occur. Seizures remain an important manifestation even in older children. Some children report headache. A sudden-onset thunderclap headache or neck, shoulder, or occipital pain should arouse suspicion of cervical artery dissection. A typical mode of presentation seen in children is a stuttering/fluctuating course of neurologic deficits. 10 This should alert the clinician to the possibility of an underlying vasculopathy involving large vessels of the circle of Willis. Recurrent TIAs also raise the possibility of a vasculopathy or a thromboembolic source. A feature unique to children is a history of paroxysmal episodes of focal neurologic dysfunction precipitated by hyperventilation, which should raise the suspicion of moyamoya. Exercise, strenuous bursts of physical activity, or excessive crying are the usual causes for hyperventilation. The mechanism underlying this phenomenon is ischemia secondary to cerebral vasoconstriction produced by carbon dioxide reduction during hyperventilation.
Based on the patient's age, awareness of stroke mimics such as focal seizures, hemiplegic migraine, demyelination, tumor with hemorrhage, hypoglycemia, and conversion disorder is important in any child with acute focal deficits. 11 Children with progressive vasculopathies such as moyamoya or medium/small vessel CNS vasculitis can present with progressive neurocognitive decline due to subtle recurrent AIS events.
CLINICAL AND HISTORICAL SEARCH FOR ETIOLOGY AND RISK FACTORS
In addition to the history pertaining to the acute presentation, a meticulous history of risk factors should also be obtained. 12 Risk factor identification informs three key management questions regarding antithrombotic therapy strategies: (1) In neonatal AIS, details of maternal, antenatal, perinatal, intrapartum, and immediate postnatal history are critical. Risk factors associated with AIS include maternal (gestational diabetes mellitus, hypertension), perinatal (perinatal depression, perinatal asphyxia, complicated delivery, instrumentation), and neonatal (congenital heart disease, dehydration, and infection). In the absence of any risk factors, a placental source of thrombosis may be considered. Placental vasculopathy may be an important but overlooked cause of perinatal AIS. 13 Placental examination can be helpful and can demonstrate placental infarction or infection, which predispose the patient to neonatal stroke.
In older children with AIS, infection, dehydration, trauma, head/neck manipulation, congenital heart disease, systemic diseases (hepatic, renal, gastrointestinal, hematologic, and rheumatologic conditions), iron deficiency anemia, and medication ingestion or substance abuse must be ruled out. Dysmorphic features, neurocutaneous markers, and connective tissue disorders may suggest syndromic genetic vasculopathy.
Risk factors common to both neonates and older children include congenital abnormalities of the coagulation/ fibrinolytic system (protein C, protein S, antithrombin, and genetic abnormalities including factor V Leiden mutation, prothrombin gene G20210A, and h omozygous thermolabile methylenetetrahydrofolate [MTHFR] mutations). A family history of thrombophilia includes myocardial infarction or stroke, deep vein thrombosis, pulmonary embolism, recurrent spontaneous miscarriages, and any family member on ''blood thinners. '' In general, perinatal/neonatal AIS tends to be a one-time event unless the patient has a risk factor such as congenital heart disease or thrombophilia.
14 In older children, recurrence risk ranges from 10% to 60% and is determined by the etiology and mechanism of stroke. 15 Some children (10% to 15%) never have a clear cause identified despite exhaustive investigations.
CONFIRMATION OF DIAGNOSIS: NEUROIMAGING
Initial imaging by CT frequently (in 40% to 80% of cases) misses evidence that would allow for AIS diagnosis. 16 Hence, MRI of the brain and magnetic resonance angiography (MRA) of the intracranial (and ideally neck) arteries is indicated for any child with suspected acute AIS. Perfusion-weighted imaging, which may be useful in determining the ischemic penumbra in adults, has not been systematically studied in children. MRA has technical limitations in newborns that may result in undercalling or overcalling of vascular abnormalities. Sedation remains a major barrier to acute MRI in young or noncooperative children, delaying the diagnosis. Collaborative institutional protocols with neuroradiology and anesthesia for emergent MRI under sedation can be helpful. CT remains an option in those who cannot get an MRI even though radiation exposure is an issue. CT angiography (CTA) in the same setting can rule out major circle of Willis abnormalities. Although MRA and CTA have increased the diagnostic yield in pediatric AIS, invasive catheter cerebral angiography still plays an important role either when MRA or CTA is unremarkable or when MRA or CTA has detected a vascular abnormality of unclear etiology. In the authors' experience, catheter cerebral angiography has been of added value in cervical artery dissection 17 Antithrombotic Therapy Antithrombotic therapy (anticoagulant or antiplatelet therapy) is applicable to vaso-occlusive territorial thromboembolic AIS only; therefore, a determination of whether the AIS pattern is vaso-occlusive or watershed/borderzone on neuroimaging is critical. Antithrombotic therapy might not be an option for watershed infarction because hypoperfusion (and not thromboembolism) is the underlying mechanism. However, the two can coexist within the same child in the setting of congenital heart disease. When considering antithrombotic therapy in any child with AIS, it is critical to continually balance the risk (hemorrhagic complication) of antithrombotic therapy with the risk of nontreatment (extension of preexisting infarction and recurrence of stroke).
Because of the lack of clinical trials, antithrombotic therapy varies considerably across centers based on physician preference. The AHA 6 and American College of Chest Physicians 7 guidelines have extensively reviewed antithrombotic therapy in pediatric AIS.
KEY POINT
h When considering antithrombotic therapy in any child with arterial ischemic stroke, it is critical to continually balance the risk (hemorrhagic complication) of antithrombotic therapy with the risk of nontreatment (extension of preexisting infarction and recurrence of stroke).
Thrombolytic therapy. IV tissue plasminogen activator (tPA) is the standard of care in adults with acute AIS and improves outcomes. In children, dose, safety, and efficacy of tPA (IV or local intra-arterial) in AIS have not been established. The risk-benefit ratio of tPA in pediatric AIS is unknown. Use of IV tPA in children for systemic thrombolysis has been associated with a higher complication rate than in adults, 20 and children with AIS rarely present within the 4.5-hour (for IV tPA) or 6-hour (intraarterial tPA) window. Given the fact that outcome from AIS in children is more favorable 21 in general than in adults, the drive to initiate IV or intra-arterial tPA even in a child presenting within the appropriate time window should be carefully scrutinized. Individual case reports that have documented successful use of tPA in children are not generalizable. 22 The American College of Chest Physicians guidelines 7 currently recommend against the use of tPA in childhood AIS outside of clinical trials. The AHA guidelines 6 take the same stance, although consensus is lacking regarding the use of tPA in older adolescents who otherwise meet the adult tPA eligibility criteria. The paucity of data with which to make any recommendations regarding mechanical thrombectomy is even greater.
An t i c o a g ul a n t th e r ap y a nd antiplatelet therapy. After the diagnosis of acute AIS, antiplatelet and anticoagulant therapies in children are usually selected based on the perceived mechanism for AIS. The rationale of initial therapy is to limit the extension of occlusive thrombosis and early recurrent thrombotic stroke, whereas subsequent maintenance therapy aims to prevent longer-term recurrence. To date, no randomized controlled trials of anticoagulant or antiplatelet therapy have been conducted in pediatric AIS. Some cohort studies have assessed safety and failure rates for anticoagulant and antiplatelet therapy 23Y25 ; the largest nonrandomized, multicenter, observational cohort study of more than 600 children was conducted via the International Pediatric Stroke Study (IPSS) group. 24 The IPSS is a growing body of pediatric stroke investigators that collects comprehensive information on pediatric stroke cases at participating centers across the world through standardized data collection forms with a central database housed in Toronto. In that IPSS cohort, initial acute therapy included anticoagulant therapy (27%), aspirin (28%), anticoagulant therapy and aspirin combination (16%), and no treatment (30%). In that study, subtypes associated with any use of anticoagulant therapy were dissection and congenital heart disease. Factors associated with nonuse of anticoagulant therapy included sickle cell disease and location of the enrollment center in the United States. Antiplatelet therapy use was more frequent in moyamoya, whereas nonuse was more frequent in dissection (anticoagulant therapy being the preferred medication), altered consciousness, and bilateral ischemia.
From a practical standpoint, consensus exists among pediatric stroke experts that some level of antithrombotic therapy is beneficial in preventing acute progression of thrombus and stroke recurrence. The authors of this article generally tend to initiate anticoagulant therapy, regardless of perceived mechanism, unless contraindications are present. Either unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) without a loading dose is preferred. UFH is chosen when the perceived risk of hemorrhagic complications is higher and a need for rapid reversal is anticipated or when invasive procedures (catheter cerebral angiography, lumbar puncture, etc) are planned. We perform a screening head CT 3 days 17 or CNS vasculitis are suspected. In moyamoya, early catheter cerebral angiography and cerebrovascular-reactivity-functional MRI (fMRI) may be helpful if surgical revascularization is indicated urgently. All cases merit cardiac echo with bubbled saline study to rule out a cardiac source of thromboembolism. Blood work that merits immediate completion on confirmation of stroke includes complete blood cell count, platelet count, international normalized ratio, partial thromboplastin time, D-dimer, electrolyte and glucose levels, and renal or liver function tests. Investigations that may be helpful in individual cases include iron profile, inflammatory markers (erythrocyte sedimentation rate, C-reactive protein, complement, von Willebrand antigen, and CSF analysis for opening pressure, cell count, protein, and cultures), serology for infectious agents, and genetic studies.
The yield and influence of prothrombotic workup on stroke management and recurrence have been recently reviewed. 27 The presence of a these disorders appears to be an important predisposing cause for thrombotic stroke, frequently acting in concert with other triggers for the stroke. A typical thrombophilia panel includes protein C, protein S, antithrombin, lupus anticoagulant, anticardiolipin antibody, factor VIII, plasma homocysteine, factor V Leiden mutation and activated protein C resistance, prothrombin gene G20210A mutation, MTHFR mutation, and lipoprotein-a. Interpretation of abnormalities in a prothrombotic workup is challenging; any abnormality on the prothrombotic workup except genetic tests should be repeated after at least 12 weeks of initial testing and off anticoagulant therapy to determine whether the abnormality was transient or persistent, as the latter may influence duration of antithrombotic therapy.
MANAGEMENT BASED ON ETIOLOGIES OF PEDIATRIC ARTERIAL ISCHEMIC STROKE
Most pediatric AIS cases fall into one of the following broad categories: perinatal/ neonatal, cardiogenic, arteriopathic (vasculopathic), prothrombotic, and idiopathic/cryptogenic. This categorization is helpful in tailoring management and estimating prognosis. Strategies for antithrombotic therapy are summarized in Perinatal/Neonatal Arterial Ischemic Stroke Antithrombotic therapy is rarely indicated in most cases because of negligible recurrence risk except in the presence of congenital heart disease 28 and abnormal prothrombotic workup. The focus of acute management is neuroprotection. Long-term management involves rehabilitation, including physiotherapy, occupational therapy, and speech therapy. Because deficits may only emerge with maturation, longitudinal observation is necessary even in apparently healthy infants. It is possible to select neonates at risk of hemiparesis for early interventions based on the presence of acute restricted diffusion signal in the corticospinal tract emanating from the zone of primary infarction and best seen in the ipsilesional cerebral peduncle on the acute MRI. This signal represents acute Wallerian degeneration 29 and reliably predicts future hemiplegia (Case 7-1). 30 Recently, constraint-induced therapy has been demonstrated to be effective in infants and children with hemiparesis due to AIS. Neuropsychological testing can be helpful during early school age.
Arterial Ischemic Stroke With
Congenital Heart Disease Multiple mechanisms interact to produce AIS in congenital heart disease: thromboembolism from valvular or septal defects, cardiac catheterization, valvular/septal devices, intracardiac A 4-day-old newborn boy presented with apneic episodes, reduced feeding, and recurrent twitching of the right upper and lower limb beginning on the third day of life. Antenatal history and pregnancy were unremarkable except the mother's history of three spontaneous miscarriages before this pregnancy, for which no cause was found. Birth was unremarkable without any complications or need for assisted delivery. Apgar scores were 7 and 9 at 1 minute and 5 minutes, respectively. The baby was well on the first 2 days, without any neurologic or systemic concerns, but he began having seizures as described above soon after he was discharged home on day 3. Neonatal neurologic examination did not reveal any focal findings. MRI of the brain revealed a large left middle cerebral artery territory stroke; magnetic resonance angiogram appeared normal. Diffusion-weighted imaging also showed the presence of restricted diffusion along the corticospinal tracts ( Figure 7-1 ). Seizures were well controlled with phenobarbital. Despite the presence of stroke, the baby was otherwise well and nonencephalopathic. Septic and prothrombotic workup was normal. Placenta was available for histopathologic examination and showed widespread thrombosis and infarction, suggesting placental vasculopathy, which was presumed to be the cause of the baby's stroke. Follow-up at 2 years of age revealed moderate-severe right-sided hemiplegia and mild language and cognitive delay. Comment. This case highlights the lack of identifiable focal deficits on neurologic examination in neonatal stroke, although in this case focal seizures were a clue. The etiology of ''idiopathic'' neonatal stroke was likely placental vasculopathy. The case also illustrates well the value of restricted diffusion in the corticospinal tract as a marker of pre-Wallerian degeneration in acute neonatal ischemic stroke and as a predictor of future hemiplegia. Antithrombotic therapy is strongly recommended for all children with congenital heart disease and AIS. Anticoagulant therapy is preferred until risk factors causing stroke are fully corrected. Antithrombotic therapy duration and type depends on the child's age, congenital heart disease, and procedure type. Details of antithrombotic therapy recommendations in congenital heart disease are available. 6, 7 Although congenital heart disease correction should theoretically eliminate the cardiogenic stroke risk, recent data demonstrate that recurrence risk remains increased for extended periods even after full congenital heart disease correction. 28 Arterial Ischemic Stroke With Arteriopathy Beyond the newborn period, arteriopathy (vasculopathy) accounts for approximately 60% of all childhood AIS and predicts stroke recurrence. 15 Steno-occlusive arteriopathies cause stroke by local in situ thrombosis, artery-to-artery embolism, or hypoperfusion. Classification has been attempted based on vessel size, distribution, the perceived pathology, temporal evolution, and genetic or nongenetic basis. 31, 32 Recognition of a radiologic pattern of a vasculopathy phenotype is beneficial in guiding management. This is feasible with judicious use of vascular imaging techniques such as MRA, CTA, catheter cerebral angiography, and arterial wall imaging. This discussion focuses on the three commonly encountered arteriopathies associated with pediatric AIS: cervical artery dissection, transient cerebral arteriopathy, and moyamoya. 33 Cervical arterial dissection. Dissection involving the intracranial or extracranial portion of the internal carotid artery (ICA) and vertebral artery (VA) causes approximately 14% of pediatric AIS cases. 34 These can occur spontaneously or in association with trivial mechanical injury or major head or neck trauma. The intradural-extradural junction of the ICA and C1-C2 portion of the VA (Case 7-2) are common sites for dissection. Stroke occurs as a result of artery-artery embolism from intimal disruption, arterial occlusion causing hypoperfusion, or distal extension of dissection along the artery wall, to disrupt the origin of branch arteries. Anticoagulant therapy is usually favored over aspirin as the first line of antithrombotic therapy in most centers, although recent adult data have suggested no difference between the two approaches. 35 Published guidelines recommend initial anticoagulant therapy for pediatric AIS with cervical artery dissection. Anticoagulant therapy duration ranges from 6 weeks to 6 months after diagnosis. Anticoagulant therapy is followed by aspirin for several years. Stroke recurrence can occur even several years after the initial event, longer than the commonly believed 6-to 12-month period. The authors consider degree of residual vessel stenosis, stroke location (brainstem at risk), and associated risk factors in deciding antithrombotic therapy duration. Anticoagulant therapy remains controversial for intracranial arterial dissection; management needs to be tailored to the individual situation.
KEY POINTS
Transient cerebral arteriopathy. Transient cerebral arteriopathy of childhood is a well-described unilateral focal arteriopathy of presumed inflammatory origin. Transient cerebral arteriopathy is characterized by basal ganglia infarction with ipsilateral irregular stenosis involving the carotid T-junction represented by the distal ICA, proximal anterior cerebral artery (ACA), and proximal MCA (Case 7-3, Figure 7- (Figure 7-2A) . Diffusion-weighted imaging revealed ischemia in the left inferior cerebellar peduncle and left pons (Figure 7-2B, Figure 7-2C) . Magnetic resonance angiography (MRA) showed greatly reduced flow in the entire left vertebral artery throughout its course (Figure 7-2D) . Unfractionated heparin was initiated as a left vertebral artery dissection was suspected. Echocardiogram, lumbar puncture, inflammatory markers, and prothrombotic blood work results were normal. Catheter cerebral angiography revealed an intimal flap and double lumen, 
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abnormalities. 36 An inflammatory basis is presumed because postvaricella angiopathy presents with an identical clinicoradiologic syndrome following varicella infection within the preceding year. In postvaricella angiopathy, varicella virus has been demonstrated in the arterial wall at the carotid T-junction on histopathology. 37 Following that description of postvaricella angiopathy, other infectious agents such as enteroviruses, Borrelia, and Bartonella have been associated with this syndrome. In addition to acute antithrombotic therapy, some children have been treated with a short course of anti-inflammatory therapy, such as high-dose corticosteroids (IV methylprednisone) followed by tapering oral doses for 6 to 12 weeks (unpublished observations). Such treatment remains controversial pending published data supporting its safety and efficacy. Acyclovir coverage can also be considered until varicella is ruled out if the patient has a history of chickenpox within a year preceding the stroke event. Follow-up imaging is helpful to decide on maintenance antithrombotic treatment, either anticoagulation or aspirin. In transient cerebral arteriopathy, the vasculopathy stabilizes by 6 months with no further worsening of the arterial findings; progression makes transient cerebral arteriopathy unlikely, raising the left vertebral artery dissection at the C1-C2 vertebral level, and occlusion of the distal third of the basilar artery (Figure 7-2E) . Unfractionated heparin was switched to low-molecular-weight heparin (LMWH). One week later, the patient had new headache, nausea, and vomiting; repeat MRI revealed a new ischemic stroke in the right pons (Figure 7-3A) . Aspirin was added; thereafter, she remained stable with no further TIAs or stroke. A 3-month follow-up catheter cerebral angiography revealed a pseudoaneurysm at the dissection site with persistent basilar artery occlusion (Figure 7-3B ). LMWH and aspirin were continued for a further 3 months. Repeat catheter cerebral angiography at 6 months was unchanged; LMWH was stopped, and aspirin was continued. Follow-up MRA at 1 year and 2 years showed a stable pseudoaneurysm. The patient remained on aspirin and made a full neurologic recovery except for a mild residual left gaze palsy.
Comment. This case illustrates the risk of recurrent stroke in the few days immediately after diagnosis of pediatric arterial ischemic stroke, particularly in the presence of vasculopathies (in this case arterial dissection), and highlights the need for close clinical and radiologic surveillance. 
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suspicion of a progressive angiitis of the CNS. The radiologic outcome of transient cerebral arteriopathy is either full recanalization of the affected arterial segments or some degree of residual stenosis that eventually may dictate the need for long-term antithrombotic therapy. Although an ''inflammatory'' basis has been presumed for this syndrome, it is important to consider other possibilities such as intracranial arterial dissection, which may have a very similar clinical and radiologic presentation. 38 Last, the possibility of unilateral moyamoya may need consideration, although if initial angiography does not demonstrate the classical hypertrophied collateral vessels, evolution to that entity appears rare. 36 
M o y a m o y a v a s c u l o p a t h y .
Moyamoya is a progressive occlusion of
Case 7-3
An 11-year-old right-handed girl who had chickenpox 7 months before but was otherwise healthy presented with stuttering right arm, leg, and facial weakness over 2 hours. Brain MRI demonstrated diffusion restriction in the left internal capsule and globus pallidus (Figure 7-4A) , with narrowing of the distal left internal carotid artery on magnetic resonance angiography (MRA) (Figure 7-4B) . MRA pattern was consistent with transient cerebral arteriopathy. High-resolution coronal T1-weighted two-dimensional fluid-attenuated inversion recovery (FLAIR) sequence demonstrated concentric wall enhancement of the distal left internal carotid artery, proximal middle cerebral artery, and proximal anterior cerebral artery, suggestive of inflammation (Figure 7-4C) , compared with the opposite side, which did not enhance. Serology was positive for varicella IgG; CSF white blood cell count was 2/mL, and CSF varicella PCR was negative. She was treated with IV methylprednisolone 30 mg/kg/d for 5 days, followed by a 3-month weaning course of oral prednisone starting at 2 mg/kg, in addition to 3 weeks of oral acyclovir. On follow-up imaging, the concentric wall enhancement was less intense by 1 month and had completely resolved by 6 months, with normalization of vessel wall caliber. Clinical recovery was complete. She remained on aspirin for secondary stroke prophylaxis.
Comment. This case illustrates the ''stuttering presentation'' of pediatric arterial ischemic stroke in the context of an arteriopathy such as postvaricella angiitis, as well as the potential utility of newer vascular imaging techniques such as high-resolution arterial wall imaging. The typical unilateral involvement (stenosis, occlusion, irregularity) of the region of bifurcation of the internal carotid artery into anterior and middle cerebral artery should also raise the suspicion of transient cerebral arteriopathy in a child with ischemic stroke. arteries of the circle of Willis, mainly the distal ICA, proximal MCA, proximal ACA, and sometimes posterior cerebral artery (PCA). The presence of hypertrophied, friable collateral vessels in the basal ganglia region (''puff of smoke'') detected by prominent flow voids on T1 MRI and the ''ivy sign'' (leptomeningeal high signal resembling creeping ivy) on fluid-attenuated inversion recovery (FLAIR) images representing prominent leptomeningeal collaterals is typical (Case 7-4). The idiopathic variety is called moyamoya disease, while that occurring in the presence of conditions such as sickle cell disease, neurofibromatosis (NF-1), and other systemic medical and genetic conditions is termed moyamoya syndrome. The condition is typically bilateral, although it can begin unilaterally and progress to the other side. In some conditions, moyamoya tends to stay unilateral, as in NF-1. Pediatric moyamoya mainly presents with ischemic stroke, whereas adult moyamoya often presents with hemorrhagic stroke. The hallmarks of moyamoya are recurrent TIAs, recurrent clinical or radiologic infarcts (mainly in central white matter), and sometimes territorial hypoperfusion-related or vasoocclusive ischemic strokes. Presentation with recurrent headaches and progressive cognitive decline is also seen. Aspirin is the favored antithrombotic therapy for stroke prophylaxis, but long-term data regarding the efficacy and safety of aspirin are lacking. Surgical 
Case 7-4
A 6-year-old boy had a history of recurrent alternating left-and right-sided face, arm, and leg weakness lasting several minutes for 3 to 4 weeks before presentation. Some of these episodes were provoked by running on the playground. He had four to five episodes of migraine-type headaches for a few months before presentation. He presented with the sudden onset of a left-sided hemiparesis that lasted longer than the previous episodes. On examination, he had persistent mild left-sided weakness. MRI showed acute patchy restricted diffusion in the right corona radiata and centrum semiovale in the deep middle cerebral artery, middle cerebral artery/anterior cerebral artery, and middle cerebral artery/posterior cerebral artery watershed zones (Figure 7-6A ). T1-weighted MRI sequence showed prominent flow voids in the basal ganglia region (Figure 7-6B) . Fluid-attenuated inversion recovery (FLAIR) sequence revealed bilateral asymmetric (right greater than left) prominent leptomeningeal high signal, consistent with an ''ivy sign'' (Figure 7-6C) . Magnetic resonance angiography (Figure 7-6D ) revealed significant stenosis of the bilateral distal internal carotid arteries and proximal middle cerebral arteries, and absent flow through both anterior cerebral arteries with bilateral moyamoya collaterals. Aspirin was started. He underwent catheter cerebral angiography, which confirmed bilateral moyamoya vasculopathy (right greater than left). Surgical revascularization (indirect bypass with bilateral pial synangiosis) was successfully performed. He remained symptom-free at the time of his last follow-up after 4 years on aspirin.
Comment. This case illustrates the peculiar presenting symptom of hyperventilation-induced (in this case, from running hard on the playground) paroxysmal episodes of focal neurologic deficits unique to moyamoya. The case also demonstrates the success of revascularization surgery in moyamoya.
FIGURE 7-6
Imaging studies at presentation of the patient in Case 7-4 A, Diffusion-weighted image (DWI) shows acute patchy restricted diffusion in the right corona radiata and centrum semiovale in the deep middle cerebral artery/anterior cerebral artery, and middle cerebral artery/posterior cerebral artery watershed zones. B, Axial T1-weighted sequence shows prominent flow voids in the basal ganglia region (arrows). C, Axial fluid-attenuated inversion recovery (FLAIR) sequence reveals bilateral asymmetric (right 9 left) prominent leptomeningeal high signal, consistent with an ''ivy sign'' (arrows). D, Magnetic resonance angiography revealed significant stenosis (blue arrows) of bilateral distal internal carotid arteries and proximal middle cerebral arteries, and absent flow through both anterior cerebral arteries with bilateral ''moyamoya'' collaterals (red arrows).
revascularization seems to have a beneficial effect in reducing the stroke risk and is generally advocated in children with clear vascular progression, recurrent stroke/TIA, and progressive cognitive decline. Surgical outcome in experienced centers is encouraging. 39 The main aim of surgery is to provide an alternative blood supply to the brain via either a direct (superficial temporal artery [STA]YMCA anastomosis) or indirect (encephaloduroarteriosynangiosis [EDAS]) external carotidYinternal carotid (EC-IC) bypass procedure. The latter involves laying of an STA branch over the cerebral surface without direct anastomosis in the hope that new vessels will eventually grow from the overlaid branch. EDAS is preferred over STA-MCA bypass in young children because the small size of the arteries makes surgery challenging.
OUTCOMES FROM PEDIATRIC ARTERIAL ISCHEMIC STROKE
Approximately 50% of neonates diagnosed with AIS will be left with a cognitive, language, or motor deficit, typically hemiparesis 40 as summarized in Table 7 -2. Death is rare. Usually, the cognitive deficits range from mild to moderate, but boys seem to do worse. 41 However, in presumed perinatal ischemic stroke, because such children come to diagnosis only because of clinical deficits (mainly hemiparesis), the outcome is of a more severe neurologic deficitVfor example, moderate to severe hemiparesis. Epilepsy occurs in 15% to 40% of patients and can occasionally be refractory. 41 Outcome from childhood AIS is summarized in Table 7 MCA syndrome. The outcome in survivors ranges from 38% normal, 42% mild disability, 8% moderate disability, to 12% severe handicap. Outcome at 1 year post stroke predicted final functional outcome, and arteriopathy predicted recurrence in one study. 20 
CONCLUSIONS
Pediatric AIS, which is probably more common than previously thought, presents unique diagnostic and management challenges that are distinct from adult AIS. A multidisciplinary approach is essential to optimize short-term and long-term management.
